SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059346
Filing Date
2018-11-13
Accepted
2018-11-13 16:04:03
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506501_10q.htm 10-Q 301517
2 EXHIBIT 10.1 tv506501_ex10-1.htm EX-10.1 216591
3 EXHIBIT 31.1 tv506501_ex31-1.htm EX-31.1 11271
4 EXHIBIT 31.2 tv506501_ex31-2.htm EX-31.2 11370
5 EXHIBIT 32.1 tv506501_ex32-1.htm EX-32.1 3724
6 EXHIBIT 32.2 tv506501_ex32-2.htm EX-32.2 3993
  Complete submission text file 0001144204-18-059346.txt   2348104

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cycc-20180930.xml EX-101.INS 306991
8 XBRL TAXONOMY EXTENSION SCHEMA cycc-20180930.xsd EX-101.SCH 27014
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycc-20180930_cal.xml EX-101.CAL 26949
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20180930_def.xml EX-101.DEF 100255
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20180930_lab.xml EX-101.LAB 263811
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20180930_pre.xml EX-101.PRE 170486
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 181177897
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1